FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103263281> ?p ?o ?g. }

• W2103263281 endingPage "42" @default.
• W2103263281 startingPage "1935" @default.
• W2103263281 abstract "The [3H]estramustine-binding macromolecule in human prostate was partially characterized using a number of chromatographic procedures. Although human estramustine-binding protein (HEMBP) had a marked tendency to aggregate in several systems, a molecular weight of about 54,000 was determined by gel filtration on Sephacryl S-200 Superfine and high-performance liquid chromatography. A sedimentation-coefficient of about 3.6S was obtained for HEMBP when analyzed by sucrose density gradient centrifugation. Isoelectric focusing in polyacrylamide gels indicated an isoelectric point of 4.7 to 4.8, which was in agreement with the elution position of HEMBP following chromatofocusing on Polybuffer Exchanger 94. Furthermore, HEMBP was eluted from diethylaminoethyl-Sepharose with 0.23 M KCl, was retained by concanavalin A-Sepharose (indicating that HEMBP is a glycoprotein), but did not interact with Affi-Gel Blue. Special efforts were concentrated on establishing that HEMBP was a species distinct from human serum albumin. Separation between the [3H]estramustine-labeled HEMBP and the [3H]estramustine-human serum albumin complex was obtained both on sucrose density gradients by chromatography on Affi-Gel Blue, by chromatofocusing, by gel filtration, by isoelectric focusing, and on concanavalin A-Sepharose by affinity chromatography. Twenty-two of 27 human benign hyperplastic prostate cytosol samples were found to contain protein immunochemically similar to estramustine-binding protein (EMBP) purified from rat ventral prostate as determined by the EMBP radioimmunoassay method. Concentrations from 0.2 to 139.6 ng EMBP per mg of total cytosolic protein (mean, 19.3) were determined. Furthermore, four of seven prostatic cancer specimens as well as two of two normal prostatic specimens were also found to contain rat EMBP-immunoreactive material. The unequivocal demonstration of the presence of a HEMBP is of great potential interest in consideration of estramustine phosphate (Estracyt) therapy against prostatic carcinoma. It is not inconceivable that the concentration of HEMBP in the carcinomatous tissue will be of significance in determining the drug uptake in the malignant tissue." @default.
• W2103263281 created "2016-06-24" @default.
• W2103263281 creator A5004514615 @default.
• W2103263281 creator A5032227006 @default.
• W2103263281 creator A5080895076 @default.
• W2103263281 creator A5085801141 @default.
• W2103263281 creator A5086213540 @default.
• W2103263281 date "1982-05-01" @default.
• W2103263281 modified "2023-09-27" @default.
• W2103263281 title "Partial characterization and quantitation of a human prostatic estramustine-binding protein." @default.
• W2103263281 cites W101694661 @default.
• W2103263281 cites W140056640 @default.
• W2103263281 cites W1503990829 @default.
• W2103263281 cites W1567844991 @default.
• W2103263281 cites W1589108012 @default.
• W2103263281 cites W1775749144 @default.
• W2103263281 cites W1941075922 @default.
• W2103263281 cites W1967882374 @default.
• W2103263281 cites W1982568517 @default.
• W2103263281 cites W1984753417 @default.
• W2103263281 cites W1996481062 @default.
• W2103263281 cites W1996529256 @default.
• W2103263281 cites W1997358099 @default.
• W2103263281 cites W1998618228 @default.
• W2103263281 cites W2002118674 @default.
• W2103263281 cites W2008756773 @default.
• W2103263281 cites W2011532428 @default.
• W2103263281 cites W2017781083 @default.
• W2103263281 cites W2045451331 @default.
• W2103263281 cites W2059554149 @default.
• W2103263281 cites W2063495675 @default.
• W2103263281 cites W2071005840 @default.
• W2103263281 cites W2080192144 @default.
• W2103263281 cites W2080939373 @default.
• W2103263281 cites W2090784961 @default.
• W2103263281 cites W2094665239 @default.
• W2103263281 cites W2147140433 @default.
• W2103263281 cites W2154551025 @default.
• W2103263281 cites W2398805807 @default.
• W2103263281 cites W2414837331 @default.
• W2103263281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7066904" @default.
• W2103263281 hasPublicationYear "1982" @default.
• W2103263281 type Work @default.
• W2103263281 sameAs 2103263281 @default.
• W2103263281 citedByCount "23" @default.
• W2103263281 crossrefType "journal-article" @default.
• W2103263281 hasAuthorship W2103263281A5004514615 @default.
• W2103263281 hasAuthorship W2103263281A5032227006 @default.
• W2103263281 hasAuthorship W2103263281A5080895076 @default.
• W2103263281 hasAuthorship W2103263281A5085801141 @default.
• W2103263281 hasAuthorship W2103263281A5086213540 @default.
• W2103263281 hasConcept C101660505 @default.
• W2103263281 hasConcept C121608353 @default.
• W2103263281 hasConcept C179247698 @default.
• W2103263281 hasConcept C181199279 @default.
• W2103263281 hasConcept C185592680 @default.
• W2103263281 hasConcept C193363816 @default.
• W2103263281 hasConcept C19869320 @default.
• W2103263281 hasConcept C202751555 @default.
• W2103263281 hasConcept C2776235491 @default.
• W2103263281 hasConcept C2776829962 @default.
• W2103263281 hasConcept C2778476535 @default.
• W2103263281 hasConcept C2778597219 @default.
• W2103263281 hasConcept C2779881004 @default.
• W2103263281 hasConcept C2780201970 @default.
• W2103263281 hasConcept C2780758401 @default.
• W2103263281 hasConcept C2994223898 @default.
• W2103263281 hasConcept C43617362 @default.
• W2103263281 hasConcept C50476208 @default.
• W2103263281 hasConcept C54355233 @default.
• W2103263281 hasConcept C55493867 @default.
• W2103263281 hasConcept C86803240 @default.
• W2103263281 hasConcept C96294017 @default.
• W2103263281 hasConceptScore W2103263281C101660505 @default.
• W2103263281 hasConceptScore W2103263281C121608353 @default.
• W2103263281 hasConceptScore W2103263281C179247698 @default.
• W2103263281 hasConceptScore W2103263281C181199279 @default.
• W2103263281 hasConceptScore W2103263281C185592680 @default.
• W2103263281 hasConceptScore W2103263281C193363816 @default.
• W2103263281 hasConceptScore W2103263281C19869320 @default.
• W2103263281 hasConceptScore W2103263281C202751555 @default.
• W2103263281 hasConceptScore W2103263281C2776235491 @default.
• W2103263281 hasConceptScore W2103263281C2776829962 @default.
• W2103263281 hasConceptScore W2103263281C2778476535 @default.
• W2103263281 hasConceptScore W2103263281C2778597219 @default.
• W2103263281 hasConceptScore W2103263281C2779881004 @default.
• W2103263281 hasConceptScore W2103263281C2780201970 @default.
• W2103263281 hasConceptScore W2103263281C2780758401 @default.
• W2103263281 hasConceptScore W2103263281C2994223898 @default.
• W2103263281 hasConceptScore W2103263281C43617362 @default.
• W2103263281 hasConceptScore W2103263281C50476208 @default.
• W2103263281 hasConceptScore W2103263281C54355233 @default.
• W2103263281 hasConceptScore W2103263281C55493867 @default.
• W2103263281 hasConceptScore W2103263281C86803240 @default.
• W2103263281 hasConceptScore W2103263281C96294017 @default.
• W2103263281 hasIssue "5" @default.
• W2103263281 hasLocation W21032632811 @default.
• W2103263281 hasOpenAccess W2103263281 @default.

• next